University Medical Center Göttingen at ESGCT 2026
Oct 27–30, 2026 Hamburg, Germany ~2.5k attendees Website
University Medical Center Göttingen brings 5 presentations to ESGCT 2026 in Hamburg. Its work centres on restoring hearing with light-sensitive proteins delivered by AAV, including promoters specific to inner ear nerve cells and biodistribution studies in primates. A second strand tests CRISPR therapy for muscular dystrophy in patient-derived heart cells.
| Organization | ESGCT 2026 Attendance |
|---|---|
University Medical Center Göttingen Göttingen, Germany | |
University medical center in Göttingen, Germany, researching optogenetic gene therapy to restore hearing. | Poster Wed Oct 28 1:30pm–3:30pm Characterization of the immune response against AAV-mediated optogene transfer in pigs Poster Wed Oct 28 1:30pm–3:30pm Preclinical Evaluation of AAV-Mediated Gene Therapy Strategies in the Common Marmoset Cochlea: Biodistribution and Biosafety Assessment Poster Thu Oct 29 2:00pm–4:00pm Characterization of promoters driving specific gene therapy in spiral ganglion neurons for optogenetic hearing restoration Poster Thu Oct 29 2:00pm–4:00pm Pre-clinical testing of all-in-one CRISPR/Cas9 AAV gene therapy for DMD in patient-specific iPSC-cardiomyocyte and skeletal muscle Talk Thu Oct 29 4:30pm–6:00pm Toward optogenetic hearing restoration Rare and inherited disease |
Instantly find 20 buyers from University Medical Center Göttingen
Get a list of who you should contact, their contact info, and what to say.
Totally free and instant, no sign up necessary!
Not affiliated with or endorsed by the European Society of Gene & Cell Therapy. Submit a correction